Swiss Re Tackles Longevity Drug Impact With Life Policy Advice
Insurance Journal - Aug 12, 2025
Swiss Re AG issued guidance for underwriters on how to assess life insurance applications of people who show signs of using medications for longevity purposes. Metformin, traditionally used to manage type 2 diabetes, and rapamycin, an immunosuppressant developed for organ …...
Recommended Articles
Posted: Sep 10, 2025
More than 60 containers toppled off a cargo ship in the Port of Long Beach, tumbling overboard and f...
Posted: Sep 10, 2025
California lawmakers have reached an initial agreement to shore up the state’s wildfire utilit...
Posted: Sep 10, 2025
East Jordan Plastics, Inc., a manufacturer of plastic horticultural containers, will pay $460,000 an...